The GI-MAP (Gastrointestinal Microbial Assay Plus) test, offered by Diagnostic Solutions Laboratory, is a comprehensive stool test designed to assess the microbiome and detect gastrointestinal pathogens. Utilizing advanced DNA sequencing technology, the GI-MAP provides detailed insights into the presence and levels of gut bacteria, viruses, parasites, and fungi, allowing for targeted interventions to restore gut health.

This test also offers a comprehensive assessment of gastrointestinal function, to aid in assessment and management of various digestive disorders including irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and gastrointestinal infections. 

The GI-MAP test analyzes over 40 different commensal and pathogenic microorganisms, including bacteria, viruses, parasites, and fungi, along with markers of inflammation and digestive function. By identifying specific pathogens and imbalances in the gut microbiome, the GI-MAP offers valuable information for healthcare providers to develop personalized treatment plans tailored to the individual's unique microbial profile.

This stool test offers a non-invasive and comprehensive approach to evaluating gut health, providing actionable insights to optimize digestion, immune function, and overall well-being. With its ability to detect a wide range of gastrointestinal pathogens and dysbiosis, the GI-MAP test serves as a valuable tool in the assessment and management of digestive disorders, allowing for targeted interventions to promote gut health and improve patient outcomes.